One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply.
Publication
, Journal Article
Chaisson, RE; Ramchandani, R; Swindells, S
Published in: N Engl J Med
September 12, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
September 12, 2019
Volume
381
Issue
11
Start / End Page
e23
Location
United States
Related Subject Headings
- Tuberculosis
- Rifampin
- Isoniazid
- Humans
- HIV
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chaisson, R. E., Ramchandani, R., & Swindells, S. (2019). One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply. N Engl J Med, 381(11), e23. https://doi.org/10.1056/NEJMc1908492
Chaisson, Richard E., Ritesh Ramchandani, and Susan Swindells. “One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply.” N Engl J Med 381, no. 11 (September 12, 2019): e23. https://doi.org/10.1056/NEJMc1908492.
Chaisson RE, Ramchandani R, Swindells S. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply. N Engl J Med. 2019 Sep 12;381(11):e23.
Chaisson, Richard E., et al. “One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply.” N Engl J Med, vol. 381, no. 11, Sept. 2019, p. e23. Pubmed, doi:10.1056/NEJMc1908492.
Chaisson RE, Ramchandani R, Swindells S. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply. N Engl J Med. 2019 Sep 12;381(11):e23.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
September 12, 2019
Volume
381
Issue
11
Start / End Page
e23
Location
United States
Related Subject Headings
- Tuberculosis
- Rifampin
- Isoniazid
- Humans
- HIV
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences